Májáttétes betegek sztereotaxiás ablatív sugárkezelésével (SABRT) elért elsõ eredményeink

Translated title of the contribution: Stereotactic body radiotherapy of liver metastasis: early experience

Gerda Földi, C. Polgár, Zsuzsánna Zongor, Barbara Melles-Bencsik, Gábor Stelczer, Balázs Madaras, T. Pintér, Éva Jederán, József Lövey

Research output: Contribution to journalArticle

Abstract

Recently the prevalence of oligometastatic patients is increasing. A common site of distant spread is the liver. The standard of care is curative surgical resection, however, the resecability rate is only 10-20%. Alternatively, radiofrequency ablation (RFA) or transarterial chemoembolization (TACE) may be used. Stereotactic ablative body radiotherapy (SABRT) makes it possible to deliver curative radiation dose without radiation injury to the healthy liver tissue. We delivered SABRT to three patients with inoperable hepatic metastases. The primary tumors were rectal (2) and lung (1). The dose was 3x20 Gy every other day. We observed one grade 1 side effect. All the metastases showed complete remission and no local recurrence or late side effect occurred during the one year of follow-up. One patient is tumor-free, one has stable disease, in one patient two new hepatic metastases appeared and receives chemo-biological therapy. SABRT of liver metastases is safe and highly effective. It can be expected that in the near future it will become one of the standard treatments of hepatic tumors.

Original languageHungarian
Pages (from-to)62-67
Number of pages6
JournalMagyar onkologia
Volume62
Issue number1
Publication statusPublished - Mar 23 2018

Fingerprint

Radiosurgery
Neoplasm Metastasis
Liver
Radiation Injuries
Biological Therapy
Standard of Care
Rectal Neoplasms
Neoplasms
Radiation
Recurrence
Lung

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Földi, G., Polgár, C., Zongor, Z., Melles-Bencsik, B., Stelczer, G., Madaras, B., ... Lövey, J. (2018). Májáttétes betegek sztereotaxiás ablatív sugárkezelésével (SABRT) elért elsõ eredményeink. Magyar onkologia, 62(1), 62-67.

Májáttétes betegek sztereotaxiás ablatív sugárkezelésével (SABRT) elért elsõ eredményeink. / Földi, Gerda; Polgár, C.; Zongor, Zsuzsánna; Melles-Bencsik, Barbara; Stelczer, Gábor; Madaras, Balázs; Pintér, T.; Jederán, Éva; Lövey, József.

In: Magyar onkologia, Vol. 62, No. 1, 23.03.2018, p. 62-67.

Research output: Contribution to journalArticle

Földi, G, Polgár, C, Zongor, Z, Melles-Bencsik, B, Stelczer, G, Madaras, B, Pintér, T, Jederán, É & Lövey, J 2018, 'Májáttétes betegek sztereotaxiás ablatív sugárkezelésével (SABRT) elért elsõ eredményeink', Magyar onkologia, vol. 62, no. 1, pp. 62-67.
Földi G, Polgár C, Zongor Z, Melles-Bencsik B, Stelczer G, Madaras B et al. Májáttétes betegek sztereotaxiás ablatív sugárkezelésével (SABRT) elért elsõ eredményeink. Magyar onkologia. 2018 Mar 23;62(1):62-67.
Földi, Gerda ; Polgár, C. ; Zongor, Zsuzsánna ; Melles-Bencsik, Barbara ; Stelczer, Gábor ; Madaras, Balázs ; Pintér, T. ; Jederán, Éva ; Lövey, József. / Májáttétes betegek sztereotaxiás ablatív sugárkezelésével (SABRT) elért elsõ eredményeink. In: Magyar onkologia. 2018 ; Vol. 62, No. 1. pp. 62-67.
@article{9e84418f6abd4923a4afadc73e7b5fac,
title = "M{\'a}j{\'a}tt{\'e}tes betegek sztereotaxi{\'a}s ablat{\'i}v sug{\'a}rkezel{\'e}s{\'e}vel (SABRT) el{\'e}rt els{\~o} eredm{\'e}nyeink",
abstract = "Recently the prevalence of oligometastatic patients is increasing. A common site of distant spread is the liver. The standard of care is curative surgical resection, however, the resecability rate is only 10-20{\%}. Alternatively, radiofrequency ablation (RFA) or transarterial chemoembolization (TACE) may be used. Stereotactic ablative body radiotherapy (SABRT) makes it possible to deliver curative radiation dose without radiation injury to the healthy liver tissue. We delivered SABRT to three patients with inoperable hepatic metastases. The primary tumors were rectal (2) and lung (1). The dose was 3x20 Gy every other day. We observed one grade 1 side effect. All the metastases showed complete remission and no local recurrence or late side effect occurred during the one year of follow-up. One patient is tumor-free, one has stable disease, in one patient two new hepatic metastases appeared and receives chemo-biological therapy. SABRT of liver metastases is safe and highly effective. It can be expected that in the near future it will become one of the standard treatments of hepatic tumors.",
author = "Gerda F{\"o}ldi and C. Polg{\'a}r and Zsuzs{\'a}nna Zongor and Barbara Melles-Bencsik and G{\'a}bor Stelczer and Bal{\'a}zs Madaras and T. Pint{\'e}r and {\'E}va Jeder{\'a}n and J{\'o}zsef L{\"o}vey",
year = "2018",
month = "3",
day = "23",
language = "Hungarian",
volume = "62",
pages = "62--67",
journal = "Magyar Onkologia",
issn = "0025-0244",
publisher = "Akademiai Kiado",
number = "1",

}

TY - JOUR

T1 - Májáttétes betegek sztereotaxiás ablatív sugárkezelésével (SABRT) elért elsõ eredményeink

AU - Földi, Gerda

AU - Polgár, C.

AU - Zongor, Zsuzsánna

AU - Melles-Bencsik, Barbara

AU - Stelczer, Gábor

AU - Madaras, Balázs

AU - Pintér, T.

AU - Jederán, Éva

AU - Lövey, József

PY - 2018/3/23

Y1 - 2018/3/23

N2 - Recently the prevalence of oligometastatic patients is increasing. A common site of distant spread is the liver. The standard of care is curative surgical resection, however, the resecability rate is only 10-20%. Alternatively, radiofrequency ablation (RFA) or transarterial chemoembolization (TACE) may be used. Stereotactic ablative body radiotherapy (SABRT) makes it possible to deliver curative radiation dose without radiation injury to the healthy liver tissue. We delivered SABRT to three patients with inoperable hepatic metastases. The primary tumors were rectal (2) and lung (1). The dose was 3x20 Gy every other day. We observed one grade 1 side effect. All the metastases showed complete remission and no local recurrence or late side effect occurred during the one year of follow-up. One patient is tumor-free, one has stable disease, in one patient two new hepatic metastases appeared and receives chemo-biological therapy. SABRT of liver metastases is safe and highly effective. It can be expected that in the near future it will become one of the standard treatments of hepatic tumors.

AB - Recently the prevalence of oligometastatic patients is increasing. A common site of distant spread is the liver. The standard of care is curative surgical resection, however, the resecability rate is only 10-20%. Alternatively, radiofrequency ablation (RFA) or transarterial chemoembolization (TACE) may be used. Stereotactic ablative body radiotherapy (SABRT) makes it possible to deliver curative radiation dose without radiation injury to the healthy liver tissue. We delivered SABRT to three patients with inoperable hepatic metastases. The primary tumors were rectal (2) and lung (1). The dose was 3x20 Gy every other day. We observed one grade 1 side effect. All the metastases showed complete remission and no local recurrence or late side effect occurred during the one year of follow-up. One patient is tumor-free, one has stable disease, in one patient two new hepatic metastases appeared and receives chemo-biological therapy. SABRT of liver metastases is safe and highly effective. It can be expected that in the near future it will become one of the standard treatments of hepatic tumors.

UR - http://www.scopus.com/inward/record.url?scp=85066488421&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066488421&partnerID=8YFLogxK

M3 - Article

VL - 62

SP - 62

EP - 67

JO - Magyar Onkologia

JF - Magyar Onkologia

SN - 0025-0244

IS - 1

ER -